Yuejin Chen
Overview
Explore the profile of Yuejin Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Liu Y, Zhu M, Chen Y, Chen D, Lin Z, et al.
Angew Chem Int Ed Engl
. 2024 Sep;
64(2):e202414473.
PMID: 39319589
Uneven Zn deposition and unfavorable side reactions have prevented the reversibility of the Zn anode. Herein, we design a rearranged (002) textured Zn anode inspired by a traditional curvature-enhanced adsorbate...
2.
Cheng J, Hua X, Zhang G, Yu M, Wang Z, Zhang Y, et al.
J Hazard Mater
. 2024 Feb;
468:133730.
PMID: 38368681
The ecological restoration of rare earth mines and the management of rare earth tailings have consistently posed global challenges, constraining the development of the rare earth industry. In this study,...
3.
Bonaccorso S, Sodhi M, Li J, Bobo W, Chen Y, Tumuklu M, et al.
Bipolar Disord
. 2015 Apr;
17(5):528-35.
PMID: 25874530
Objectives: We tested the hypothesis that a common functional variant in brain-derived neurotrophic factor (BDNF), Val66Met, which has been shown to be associated with increased body mass index (BMI) in...
4.
Cui F, Li M, Chen Y, Liu Y, He Y, Jiang D, et al.
PLoS One
. 2014 Aug;
9(8):e104299.
PMID: 25093861
The aim of the study is to investigate the radioprotective effect of polysaccharide extract from Sipunculus nudus (SNP). Beagle dogs were randomly divided into the following six groups. Group-1: Un-treated...
5.
Chen Y, Bobo W, Watts K, Jayathilake K, Tang T, Meltzer H
J Psychopharmacol
. 2012 Jan;
26(9):1201-10.
PMID: 22234928
We studied the effects of switching antipsychotic drug-treated patients with schizophrenia or bipolar disorder who evidenced adverse metabolic side effects as indicated by a triglyceride/high-density lipoprotein ratio (TG/HDL) ≥ 3.5...
6.
Meltzer H, Bonaccorso S, Bobo W, Chen Y, Jayathilake K
J Clin Psychiatry
. 2011 Aug;
72(12):1602-10.
PMID: 21813074
Objective: Longitudinal data comparing the metabolic effects of olanzapine and risperidone with or without valproic acid supplementation in schizophrenic and bipolar patients are lacking. Method: This study compares the metabolic...
7.
Meltzer H, Bobo W, Roy A, Jayathilake K, Chen Y, Ertugrul A, et al.
J Clin Psychiatry
. 2008 Feb;
69(2):274-85.
PMID: 18232726
Background: Clozapine, despite its side-effect burden, has been considered to be the drug of choice for patients with schizophrenia whose psychotic symptoms fail to respond adequately to other anti-psychotic drugs....